Completed cytometry lab
Billerica, MA – Erland Construction was selected by EMD Serono, Inc., the U.S. biopharmaceutical business of Merck KGaA, Darmstadt, Germany, to manage multiple phased projects at the company’s Billerica campus.
During the first three phases of construction, Erland is renovating two labs and building new clean rooms inside Serono’s research center. Future projects to accommodate the growth of the company in the Boston area are already in the early stage of planning.
EMD Serono, Inc. is engaged in the discovery, research, and development of specialty care medicines for patients with difficult-to-treat diseases. As the fifth largest life sciences company in Massachusetts combined with MilliporeSigma, the life sciences business of Merck KGaA, Darmstadt, Germany, EMD Serono recently invested in expanding its research and development presence in the state.
As construction moves forward, Erland is planning and performing numerous renovations and expansion work, as well as critical infrastructure work.
-more-
“EMD Serono selected Erland as a partner for multiple reasons, including our commitment to safety and experience, as well as our broader company mission,” Tony Meenaghan, Senior Director of Facilities, EMD Serono, Inc. “Erland understands how important it is for us to have the right space and the right tools to continue our mission of developing and delivering meaningful therapies for people impacted by difficult-to-treat diseases.”
“We’re really proud to be working with EMD Serono. Not only does their culture align with ours at Erland, but our views on safety go hand-in-hand,” said Dan Cobb, Advanced Technology/Life Sciences Manager, Erland. “It’s also exciting to be able to support their ultimate goal of transforming patient lives by providing them with the latest technological advances in construction.”
